Physician profile
Babak Behin
NPI 1205931466
$1,629.19
in general payments reported to CMS, 2019-2025
16 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $49.41 · 2021: $66.35 · 2022: $203 · 2023: $272 · 2024: $455 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.35 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $449.46 | 2019-2025 | Dupixent |
| Genzyme Corporation | $330.80 | 2023-2025 | |
| Optinose US, INC. | $213.11 | 2019-2025 | |
| Aerin Medical INC. | $127.27 | 2022-2024 | |
| Stryker Corporation | $119.19 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $66.90 | 2020-2025 | Tezspire |
| Glaxosmithkline, LLC. | $56.60 | 2022-2023 | Nucala |
| Smith+Nephew, INC. | $54.61 | 2019 | |
| Sanofi-Aventis U.S. LLC | $52.99 | 2024 | |
| Alk-Abello, INC | $49.61 | 2019-2021 | |
| Inspire Medical Systems, INC. | $29.32 | 2024 | Inspire |
| Intersect Ent, INC. | $19.37 | 2019 | |
| Amgen INC. | $16.92 | 2025 | Tezspire |
| Hikma Pharmaceuticals USA | $16.87 | 2024 | Ryaltris |
| Merck Sharp & Dohme LLC | $14.17 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glenmark Therapeutics INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Behin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.